SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|Date of Report (Date of Earliest Event Reported):||December 17, 2004|
LAIDLAW INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
|of incorporation)||File Number)||Identification No.)|
|55 Shuman Blvd. Suite 400, Naperville, Illinois||60563|
(Address of principal executive offices)
|Registrants telephone number, including area code:||(630) 848-3000|
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
On December 17, 2004, the lenders under the Laidlaw International, Inc. ("Laidlaw") Credit Agreement dated June 19, 2003, by and among Laidlaw, Laidlaw Transit Ltd., and Greyhound Canada Transportation Corp. (collectively, the "Borrowers"), Citicorp North America, Inc., as administrative agent and the other lenders party thereto (as amended or modified from time to time, the "Credit Agreement"), consented to Laidlaw’s disposition of its healthcare group, comprised of American Medical Response, Inc., EmCare Holdings Inc. and each of their respective direct and indirect subsidiaries (the "Sale Transaction"); provided Laidlaw use a portion of the proceeds from the Sale Transaction to repay in full the outstanding principal amount of the Term B Revolver and any accrued and unpaid interest thereon. The lenders further agreed, in accordance with the terms of the Bank Consent Letter (as defined below), to release (i) the guarantees granted by AMR, EmCare and their subsidiaries and (ii) all liens on all of the assets of AMR, EmCare and their subsidiaries, upon consummation of the Sale Transaction. Attached hereto is the bank consent letter dated December 17, 2004, by and among the Borrowers, Citicorp North America, Inc. and certain of the other lenders under the Credit Agreement (the "Bank Consent Letter").
Item 9.01. Financial Statements and Exhibits.
99.1 Bank Consent Letter.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|LAIDLAW INTERNATIONAL, INC.|
|December 17, 2004||By:||
Douglas A. Carty
|Name: Douglas A. Carty|
|Title: Senior Vice President and Chief Financial Officer|
|Bank Consent Letter|